SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-20-135734
Filing Date
2020-12-15
Accepted
2020-12-15 16:14:58
Documents
2
Group Members
JEREMY C. GREENREDMILE CAPITAL OFFSHORE MASTER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2038546d1_sc13da.htm SC 13D/A 118985
2 EXHIBIT 99.8 tm2038546d1_ex99-8.htm EX-99.8 6822
  Complete submission text file 0001104659-20-135734.txt   127511
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Subject) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91132 | Film No.: 201389759
SIC: 2834 Pharmaceutical Preparations